Background
LizardTech, Inc. held U.S. Patent No. 5,710,835 on methods for computing discrete wavelet transforms (DWTs) of digital images using limited memory. Wavelet transforms are mathematical tools used in image compression — the same fundamental technology behind many image formats and standards. The specific problem the invention solved was that when a large image is divided into tiles for memory-efficient processing, visible seam artifacts appear at the edges where tiles meet. LizardTech’s patent disclosed a method of computing DWT coefficients for pixels outside each tile and adding them to adjacent tiles, creating seamless compressed results.
LizardTech sued Earth Resource Mapping (ERM) for infringement. ERM’s ER Mapper software also produced seamless DWT results, but did so using a fundamentally different algorithm — computing coefficients row-by-row and then column-by-column, keeping only one row or column in memory at a time. The narrower claims of the LizardTech patent (claims 1 and 13) required the specific “maintaining updated sums” approach, and the district court found those claims were not infringed by ERM’s different method. But claim 21 — a broader claim that omitted that specific limitation — could potentially cover ERM’s approach.
The Court’s Holding
The Federal Circuit affirmed the district court’s finding of invalidity as to claim 21 and its dependent claims, holding that they failed the written description requirement of 35 U.S.C. § 112. The written description requirement demands that the patent specification actually describe the claimed invention — not just the specific embodiment disclosed, but all of the subject matter the claims encompass.
Claim 21, by removing the “maintaining updated sums” limitation from claim 1, purported to cover every method of seamlessly computing DWTs — including methods not described anywhere in the patent specification. Because the specification disclosed only one way of achieving a seamless DWT (LizardTech’s specific approach), LizardTech had no written description support for the much broader class of methods that would be needed to justify claim 21’s scope. The court drew the line clearly: if you want a claim that covers all ways of achieving a result, you must describe all of those ways (or at least a representative range) in your specification.
The court rejected LizardTech’s argument that claim 21 was merely a simplified version of claim 1 and should be interpreted more narrowly. Claims without limiting language must be given their full scope, and that scope exceeded what LizardTech had actually invented and disclosed.
Key Takeaways
- The written description requirement of 35 U.S.C. § 112 limits the scope of patent claims to what the inventor actually described in the specification — generic claims covering all solutions to a problem require generic or multiple embodiments in the specification to support them.
- A patent claim is not automatically entitled to a narrowing construction merely because the claims as literally read are broader than what was disclosed; if the claim language is broad, it must be supported by broad disclosure.
- Dependent claims that rely on an invalid independent claim are also invalid.
- Software and algorithmic inventions are particularly vulnerable to written description challenges when a patent claims a functional result without disclosing multiple ways to achieve that result.
- Patent drafters should ensure that every scope of claim they want to assert is supported by corresponding disclosure in the specification, or narrow the claim to match the described embodiments.
Why It Matters
LizardTech is a landmark illustration of the written description requirement functioning as a check on overbroad claiming — the strategy of disclosing a specific invention while writing claims broad enough to cover all possible ways of achieving a desired outcome. The Federal Circuit’s message was clear: patents protect what is actually described, not what the inventor might wish had been described.
The decision had significant practical implications for software and technology patents, where inventors routinely disclose specific algorithms or implementations but write claims that purport to cover any functional equivalent. It remains a commonly cited authority for the principle that genus claims require commensurate genus disclosure, and it is frequently cited alongside other written description landmark cases such as Gentry Gallery, Inc. v. Berkline Corp. (Fed. Cir. 1998) and Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. (Fed. Cir. 2010, en banc).